Importance of long-term low-dose CT follow-up after negative findings at previous lung cancer screening

Radiology

Volumn 289, Issue 1, 2018, Pages 218-224

  Kavanagh, John ^a   Liu, Geoffrey ^b   Menezes, Ravi ^a   O'Kane, Grainne M ^b   McGregor, Maureen ^b   Tsao, Ming ^c   Shepherd, Frances A ^b   Schmidt, Heidi ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT RISK; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREND STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85054683916     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2018180053     Document Type: Article

References (30)

1. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362 (9384): 593-597.
2. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008; 61 (3): 340-349.
3. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165 (4): 508-513.
4. Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer 2010; 67 (2): 177-183.
5. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008; 178 (9): 956-961.
6. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355 (17): 1763-1771.
7. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial: overall design and results of the prevalence round. J Thorac Oncol 2009; 4 (5): 608-614.
8. Lopes Pegna A, Picozzi G, Falaschi F, et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol 2013; 8 (7): 866-875.
9. Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004; 126 (1): 114-121.
10. Becker N, Motsch E, Gross ML, et al. Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol 2015; 10 (6): 890-896.
11. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012; 21 (3): 308-315.
12. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012; 67 (4): 296-301.
13. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013; 42 (6): 1659-1667.
14. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365 (5): 395-409.
15. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120 (4): 868-874.
16. Lung cancer screening pilot for people at high risk. Cancer Care Ontario. https://www.cancercareontario.ca/en/guidelines-advice/cancer-continuum/screening/lung-cancer-screening-pilot-people-at-high-risk. Published 2017. Accessed November 28, 2017.
17. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368 (8): 728-736.
18. Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014; 11 (12): e1001764
19. Published correction appears in PLoS Med 2015; 12 (1): e1001787.
20. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013; 369 (10): 910-919.
21. Henschke CI, McCauley DI, Yankelevitz D F, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354 (9173): 99-105.
22. Pinsky PF, Gierada DS, Hocking W, Patz EF Jr, Kramer BS. National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med 2014; 161 (9): 627-633.
23. Lubin JH, Caporaso N, Wichmann HE, Schaffrath-Rosario A, Alavanja MCR. Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiology 2007; 18 (5): 639-648.
24. Shlomi D, Ben-Avi R, Balmor GR, Onn A, Peled N. Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 2014; 44 (1): 217-238.
25. Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016; 17 (5): 590-599.
26. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014; 15 (12): 1342-1350.
27. Duffy SW, Field JK, Allgood PC, Seigneurin A. Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer 2014; 110 (7): 1834-1840.
28. Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014; 9 (11): 1618-1624.
29. Infante M, Berghmans T, Heuvelmans MA, Hillerdal G, Oudkerk M. Slow-growing lung cancer as an emerging entity: from screening to clinical management. Eur Respir J 2013; 42 (6): 1706-1722.
30. Kakinuma R, Muramatsu Y, Kusumoto M, et al. Solitary pure ground-glass nodules 5 mm or smaller: frequency of growth. Radiology 2015; 276 (3): 873-882.